Philip Lee

Philip Lee serves as Chief Executive Officer at GeneFab. GeneFab operates in the research sector with approximately 71.0 employees. The company is headquartered in South San Francisco, California.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 3 executives at GeneFab.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Salesforce Outlook Google Cloud Hosting Wix Mobile Friendly Varnish Lever Remote

cell therapy gene therapy synthetic biology mrna lnp synthetic biology target discovery outsourced r d biotechnology research cell therapies gene therapies clinical manufacturing gmp compliance viral vectors cell banking technology transfer process development analytical development candidate selection ind enabling studies clinical trial materials cell therapy platforms gene circuit design custom promoters high throughput screening autologous cells allogeneic cells car t cells manufacturing optimization qc testing biomanufacturing pharmaceutical development therapeutic applications environmental monitoring stability studies product storage gene delivery regenerative medicines innovation project management collaborative tools research expertise quality control drug development lifecycle data sharing cloud-based tools technical development milestone achievement risk minimization project alignment biotech partnership product design commercialization support scalable production bioengineering biotechnology productivity

EB

Eric Blair Global Chief Business Officer (CBO) & Singapore Country Executive Officer at GeneFab

DJ

Drew Johnston Chief Operating Officer at GeneFab

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

Outreach Guidance — research Sector

Executives like Philip Lee in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at GeneFab.

Philip Lee's Position in the MessageCEO Database

• •Philip Lee is 1 of 3 verified executive contacts we track at GeneFab.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •12,901 verified executive contacts in California are in the database.
• •17 verified contacts work at research companies in the 71.0 employee range (same size as GeneFab).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Philip Lee directly?

Philip Lee's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at GeneFab. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Philip Lee work for?

Philip Lee is Chief Executive Officer at GeneFab, a company in the research sector with 71.0 employees. The company is based in South San Francisco, California.

Can I pitch or sell to Philip Lee?

As Chief Executive Officer at GeneFab, Philip Lee is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Philip Lee directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Philip Lee in?

Philip Lee works in the research industry as Chief Executive Officer at GeneFab. MessageCEO provides verified contact information for executives across all major industries.

Is Philip Lee's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Philip Lee's profile is kept up-to-date with the latest available information.

Last updated: June 26, 2026